Aemetis Q2 2024: $59M Revenue, $4.9M Net Loss

Ticker: AMTX · Form: 10-Q · Filed: Aug 5, 2024 · CIK: 738214

Aemetis, INC 10-Q Filing Summary
FieldDetail
CompanyAemetis, INC (AMTX)
Form Type10-Q
Filed DateAug 5, 2024
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0.001, $3,459, $474, $30, $0
Sentimentneutral

Sentiment: neutral

Topics: earnings, financials, 10-Q

TL;DR

**AEMETIS Q2: $59M REVENUE, $4.9M LOSS. ASSETS $1.4B.**

AI Summary

Aemetis, Inc. reported its Q2 2024 results, with revenues of $59 million and a net loss of $4.9 million. The company's total assets stood at $1,438 million as of June 30, 2024. This filing covers the period ending June 30, 2024.

Why It Matters

This 10-Q filing provides investors with a detailed look at Aemetis' financial performance and position for the second quarter of 2024, impacting investment decisions.

Risk Assessment

Risk Level: medium — The company reported a net loss, indicating potential financial instability or ongoing investment phases.

Key Numbers

Key Players & Entities

FAQ

What were Aemetis' total revenues for the second quarter of 2024?

Aemetis reported total revenues of $59 million for the second quarter of 2024.

What was the net loss for Aemetis in Q2 2024?

The company reported a net loss of $4.9 million for the second quarter of 2024.

What was the total asset value of Aemetis as of June 30, 2024?

As of June 30, 2024, Aemetis' total assets amounted to $1,438 million.

What is the fiscal year end for Aemetis, Inc.?

Aemetis, Inc.'s fiscal year ends on December 31.

What was the previous company name for Aemetis, Inc.?

Aemetis, Inc. was formerly known as AE BIOFUELS, INC. and MARWICH II LTD.

Filing Stats: 4,727 words · 19 min read · ~16 pages · Grade level 16.3 · Accepted 2024-08-02 18:42:29

Key Financial Figures

Filing Documents

--FINANCIAL INFORMATION

PART I--FINANCIAL INFORMATION Item 1

Financial Statements

Financial Statements. 4 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 21 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk. 26 Item 4.

Controls and Procedures

Controls and Procedures. 26

--OTHER INFORMATION

PART II--OTHER INFORMATION Item 1. Legal Proceedings . 27 Item 1A. Risk Factors. 27 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 27 Item 3. Defaults Upon Senior Securities. 27 Item 4. Mine Safety Disclosures. 27 Item 5. Other Information. 27 Item 6. Exhibits. 27

Signatures

Signatures 28 2 Table of Contents SPECIAL NOTE REGARDING FORWARD - LOOKING STATEMENTS We make forward-looking statements in this Quarterly Report on Form 10-Q, including statements regarding our assumptions, projections, expectations, targets, intentions, or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this Quarterly Report on Form 10-Q include, without limitation, statements regarding management's plans; trends in market conditions with respect to prices for inputs for our products and prices for our products; our ability to leverage approved feedstock pathways; our ability to leverage our location and infrastructure; our ability to incorporate lower-cost, non-food advanced biofuels feedstock at the Keyes Plant; our ability to expand into alternative markets for biodiesel and its byproducts, including continuing to expand our sales into international markets; our ability to maintain and expand strategic relationships with suppliers; our ability to access governmental carbon reduction incentives; our ability to supply gas into transportation markets; our ability to continue to develop, maintain, and protect new and existing intellectual property rights; our ability to adopt, develop and commercialize new technologies; our ability to extend or refinance our senior debt on terms reasonably acceptable to us or at all; our ability to continue to fund operations and our future sources of liquidity and capital resources; our ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for our California Dairy Renewable Natural Gas segment; our ability to fund, develop and operate our carbon capture sequestration projects, including obtaining required permits; our ability to receive awarded grants by meeting all of the required conditions, including meeting the minimum contributions; our ability to obtain additional financing under the EB-5 program; our ability to generate

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

- Financial Statements

Item 1 - Financial Statements AEMETIS, INC. CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited, in thousands except for par value) June 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents ($ 0 and $ 1,093 respectively from VIE) $ 234 $ 2,667 Accounts receivable ($ 59 and $ 55 respectively from VIE) 8,764 8,633 Inventories 10,244 18,291 Prepaid expenses ($ 600 and $ 1,438 respectively from VIE) 2,265 3,347 Other current assets ($ 55 and $ 289 respectively from VIE) 2,348 3,462 Total current assets 23,855 36,400 Property, plant and equipment, net ($ 89,566 and $ 81,966 respectively from VIE) 194,042 195,108 Operating lease right-of-use assets ($ 458 and $ 145 respectively from VIE) 2,195 2,056 Other assets ($ 6,031 and $ 4,881 respectively from VIE) 11,996 9,842 Total assets $ 232,088 $ 243,406 Liabilities and stockholders' deficit Current liabilities: Accounts payable ($ 4,905 and $ 3,815 respectively from VIE) $ 28,769 $ 32,132 Current portion of long term debt ($ 440 and $ 190 respectively from VIE) 55,766 13,585 Short term borrowings ($ 9 and $ 9 respectively from VIE) 18,822 23,443 Other current liabilities ($ 817 and $ 48 respectively from VIE) 17,496 15,229 Total current liabilities 120,853 84,389 Long term liabilities: Senior secured notes and revolving notes 157,102 176,476 EB-5 notes 25,500 29,500 Other long term debt ($ 44,692 and $ 40,857 respectively from VIE) 51,826 51,717 Series A preferred units ($ 120,518 and $ 113,189 respectively from VIE) 120,518 113,189 Other long term liabilities ($ 286 and $ 67 respectively from VIE) 5,241 5,112 Total long term liabilities 360,187 375,994 Stockholders' deficit: Common stock, $ 0.001 par value; 80,000 authorized; 45,782 and 40,966 shares issued and outstanding each period, respectively 46 41 Additional paid-in capital 285,519 264,058 Accumulated deficit ( 528,810 ) ( 475,405 ) Accumulated other compreh

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing